Clinical Trials Directory

Trials / Completed

CompletedNCT03859024

Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigator's study aims to see if an enhanced recovery regimen of pain medications before and during surgery will decrease the use and risk of opioid pain medications as well as improve pain control in anterior urethroplasty patients. Participants will be randomized to one of two pain regimens (enhanced recovery regimen vs standard regimen).

Detailed description

The purpose of this study is to assess the difference in narcotics usage between two different pain management protocols after urethroplasty. Management at the current time varies between giving intraoperative painkillers along with peripheral nerve blocks in some patients, while others do not receive this protocol. In this study, one group will continue the historical standard of care of the hospital, receiving postoperative nonsteroidal anti-inflammatory drugs (NSAIDs) and narcotics for pain control. The other group will utilize a protocol to lower narcotics usage, including acetaminophen, gabapentin, Celebrex, and local anesthetic (bupivacaine) in an attempt to reduce the usage of narcotics postoperatively. Given the heightened concern over narcotic usage by postoperative patients, including the risk of chronic usage by even young patients, the objective will be to assess if using this protocol as a new standard can limit the need for postoperative narcotics prescriptions. In related urological procedures, bupivacaine injections given before surgeries have been shown to significantly lower pain scores after surgery for patients undergoing penile prosthesis. The University of Alabama at Birmingham has also been using an Enhanced Recovery After Surgery (ERAS) protocol, a multimodal presurgical care pathway designed to achieve early recovery after surgical procedures, for cystectomy and seen reduced narcotic usage among those patients. This study would potentially help determine a new pain management protocol for urology patients undergoing anterior urethroplasty that is both more effective and less risky.

Conditions

Interventions

TypeNameDescription
DRUGOxycodoneoxycodone tablet
DRUGAcetaminophenacetaminophen tablet
DRUGGabapentingabapentin tablet
DRUGcelebrexCelebrex tablet
DRUGBupivacainebupivacaine injection
DRUGIbuprofen 800 mgibuprofen tablet
DRUGDexamethasoneDexamethasone injection

Timeline

Start date
2019-03-22
Primary completion
2023-04-30
Completion
2023-06-30
First posted
2019-03-01
Last updated
2024-09-19
Results posted
2024-09-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03859024. Inclusion in this directory is not an endorsement.